Healthcare Scan
Scan
Healthcare Scan
raw scan snapshot — prices as of scan date, not live 26 rows · screens, not recommendations superseded by2026-04-26-healthcare-scanported fromresearch/classic/scans/_archive/2026-03-24-healthcare-scan.mdscan slughealthcare-scansource typescan-archive
Healthcare in systemic distribution — SYK RSI 29 with death cross, MDT RSI 30, LLY RSI 30 continuing slide. MRNA (+58% 3M) and JNJ (+14% 3M) provide isolated pockets of strength. UNH death cross persists (-44.6% 1yr). Several tickers (ABT, PFE, MRK, CVS) have no data.
Quick Snapshot
| Signal | Reading |
|---|---|
| Overall | 🔴 BEARISH / SECTOR-WIDE SELLOFF — Medical devices, managed care breaking down; only select biotech/pharma holding |
| Leaders | MRNA ($51.60, RSI 52, +57.6% 3M), JNJ ($235.32, RSI 42, +13.9% 3M), BIIB ($183.81, RSI 47) |
| Laggards | SYK ($328.81, RSI 29↓, -13.8% 30D), MDT ($86.85, RSI 30↓), UNH ($278.27, death cross) |
Price Table
| Stock | Price | RSI | vs SMA20 | 7D% | 30D% | 3M% | Trend | Signal |
|---|---|---|---|---|---|---|---|---|
| MRNA | $51.60 | 52 | -2.9% | -6.7% | +2.1% | +57.6% | strong-up ✨ | 🔒 Hold |
| JNJ | $235.32 | 42 | -2.6% | -2.5% | -4.5% | +13.9% | strong-up ✨ | 🟡 Watch |
| BIIB | $183.81 | 47 | -1.2% | -0.8% | -5.8% | +4.2% | weak-down | 🟡 Watch |
| VEEV | $184.23 | 46 | -0.3% | +1.3% | +2.2% | -17.5% | strong-down 💀 | 🟡 Watch |
| TMO | $492.20 | 46 | -0.2% | +0.4% | -4.4% | -14.9% | down | 🟡 Watch |
| VRTX | $455.65 | 44 | -3.9% | -3.4% | -4.5% | -1.0% | weak-down | 🟡 Watch |
| UNH | $278.27 | 43 | -2.0% | -0.2% | -3.3% | -13.8% | strong-down 💀 | 🟡 Watch |
| DXCM | $66.73 | 42 | -4.2% | -3.5% | -8.7% | -0.9% | strong-down 💀 | 🟡 Watch |
| AMGN | $349.97 | 38 | -5.0% | -4.3% | -8.6% | +5.6% | weak-down | 🟡 Watch |
| ISRG | $473.88 | 38 | -3.0% | -2.4% | -4.1% | -17.9% | strong-down 💀 | 🟡 Watch |
| GILD | $137.06 | 37 | -4.8% | -5.1% | -6.6% | +9.7% | weak-down | 🟡 Watch |
| LLY | $901.47 | 30 ↓ | -7.8% | -5.1% | -13.5% | -16.2% | weak-down | 🟢 Oversold |
| MDT | $86.85 | 30 ↓ | -4.6% | -2.0% | -10.2% | -10.1% | down | 🟢 Oversold |
| SYK | $328.81 | 29 ↓ | -8.3% | -5.8% | -13.8% | -7.1% | strong-down 💀 | 🟢 Oversold |
Entry Zones
| Stock | Entry Zone | RSI | Thesis |
|---|---|---|---|
| SYK | $320-335 | 29 | Premium medtech at rare oversold level |
| LLY | $880-910 | 30 | GLP-1 franchise at oversold |
| MDT | $84-88 | 30 | Medtech staple, deep discount |
Action Matrix
| Stock | Signal | Action | Notes |
|---|---|---|---|
| MRNA | ✨ Strong-Up | 🔒 Hold | Vaccine/mRNA rebound, +58% 3M |
| JNJ | ✨ Strong-Up | 🔒 Hold | Defensive pharma working |
| SYK | 🟢 Oversold | 📈 Accumulate | RSI 29, death cross is risk |
| LLY | 🟢 Oversold | 📈 Accumulate | RSI 30, rare opportunity |
| UNH | 💀 Death Cross | 🔍 Watch | Structural issues, -44.6% 1yr |
| ISRG | 💀 Death Cross | 🔍 Watch | Premium valued, needs stabilization |
Related
10 eventsNo direct external sources are attached to this read.